A targeted proteomics approach to the rapid identification of bacterial cell mixtures by matrix-assisted laser desorption/ionization mass spectrometry

Proteomics
Bettina Warscheid, Catherine Fenselau

Abstract

A proteomic approach to the rapid identification of bacteria is presented, which relies on the solubilization of a limited number of proteins from intact cells combined with on-probe tryptic digestion. Within 20 min, complete cleavage products of a limited set of bacterial proteins with molecular masses of about 4-125 kDa were obtained by on-probe digestion with immobilized trypsin. Bacterial peptides suitable for unimolecular decomposition analysis were generated within 5 min, and the sequence information obtained allowed identification of abundant proteins, and accordingly, their bacterial sources via searches in the NCBI database. Analysis of fragmentation products was also shown to allow for identification of bacterial peptides identical in mass but differing slightly in amino acid sequence by manual data analysis. In this work, Bacillus subtilis 168, B. globigii, B. sphaericus 14577, B. cereus T, and B. anthracis Sterne were examined, and various cold shock proteins were identified in all species. In addition, DNA-binding, 60 kDa-heat shock, surface-related and other stress-protective proteins were identified in the bacterial cell digests, and species-specific tryptic peptides could be generated from each of the Bacillus s...Continue Reading

Citations

Sep 28, 2012·Science China. Life Sciences·FangWei Leng
Mar 17, 2005·Biochimica Et Biophysica Acta·Anthony W FrancisSrinivas Iyer
Apr 6, 2005·FEMS Microbiology Reviews·David A RaskoJacques Ravel
Feb 21, 2006·Journal of the American Society for Mass Spectrometry·Xu ZhangLloyd M Smith
Apr 7, 2010·Applied and Environmental Microbiology·Rabih E JabbourA Peter Snyder
Oct 15, 2005·Clinical Microbiology Reviews·Daniel V LimMarianne F Kramer
Jul 19, 2008·Annual Review of Analytical Chemistry·Plamen A Demirev, Catherine Fenselau
May 17, 2005·Expert Review of Proteomics·Richard R DrakeStefan Gravenstein
Nov 26, 2005·Expert Review of Proteomics·Jacek P Dworzanski, A Peter Snyder
Sep 16, 2008·Analytica Chimica Acta·Alton J Dugas, Kermit K Murray
May 26, 2005·Rapid Communications in Mass Spectrometry : RCM·John M KoomenRyuji Kobayashi
Aug 23, 2008·Journal of Mass Spectrometry : JMS·Plamen A Demirev, Catherine Fenselau
Jan 22, 2011·Mass Spectrometry Reviews·Pawel L UrbanRenato Zenobi
May 11, 2011·Mass Spectrometry Reviews·Yen-Peng Ho, P Muralidhar Reddy
Jan 28, 2014·Journal of Microbiological Methods·Lukáš KrásnýIgor Hochel
Nov 30, 2007·Molecular & Cellular Proteomics : MCP·Sen-Yung HsiehJen-Kun Chen
Sep 20, 2007·European Journal of Mass Spectrometry·C FenselauN Edwards
Sep 15, 2005·Analytical Chemistry·Patrick Pribil, Catherine Fenselau
Jan 7, 2006·Journal of Proteome Research·Jacek P DworzanskiLiang Li
Jul 4, 2008·Journal of Proteome Research·Melkamu Getie-KebtieMichail A Alterman
Dec 31, 2005·Analytical Chemistry·Stephen SwatkoskiCatherine Fenselau
Nov 16, 2005·Analytical Chemistry·Plamen A DemirevJeffrey S Lin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.